Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91), a small biopharmaceutical company with an $8 million market cap, has launched…
Read More »Biotech
The multiple sclerosis (MS) treatment market, valued at over $20 billion annually, is experiencing a transformative phase. With no definitive…
Read More »
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91), a biopharmaceutical company dedicated to building a portfolio of innovative assets and…
Read More »
WealthyVC.com scans North America’s 10,000+ publicly listed stocks across all seven exchanges to find the market-moving news that matters. Our…
Read More »
WealthyVC.com scans North America’s 10,000+ publicly listed stocks across all seven exchanges to find the market-moving news that matters. Our…
Read More »
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) is rapidly positioning itself as a transformative player in the biotech and…
Read More »
When investors think of the best-performing stocks in the market the first names that come to mind are big tech…
Read More »
Markets sent a clear message Friday following President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. to head the Department…
Read More »
WealthyVC.com scans North America’s 10,000+ publicly listed stocks across all seven exchanges to find the market-moving news that matters. Our…
Read More »
Neurogene (NASDAQ: NGNE), a genetic medicine company, saw its stock skyrocket by 43% on Monday following news of a $200…
Read More »